Genetic mapping of the embryonal carcinoma transplantation resistance locus Gt(B6) to mouse Chromosome 8

Immunogenetics

Volumn 49, Issue 11-12, 1999, Pages 949-956

  Muller, Alexander J ^a   Heiden, Katherine B ^b   Teresky, Angelika K ^a   Levine, Arnold J ^c  

^a PRINCETON UNIVERSITY   (United States)

^b The New York Presbyterian Hospital   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Embryonal carcinoma; Histocompatibility; Mouse Chromosome 8; Teratocarcinoma; Transplantation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 8; CHROMOSOME MAP; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYONAL CARCINOMA; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GRAFT REJECTION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY GENE; MALE; MARKER GENE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; CARCINOMA, EMBRYONAL; CHROMOSOME MAPPING; CROSSES, GENETIC; GRAFT REJECTION; IMMUNITY, NATURAL; LINKAGE (GENETICS); MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032869049     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050578     Document Type: Article

References (44)

1. Aldridge W (1993) The esterases: perspectives and problems. Chem Biol Interact 87:5-13
2. Artzt K, Jacob F (1974) Letter: Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture. Transplantation 17:632-634
3. Avner P, Simmler MC (1982) Genetics of teratocarcinoma transplantation. III. Genetic control of resistance to F9 tumor formation in allogeneic hosts. J Reprod Immunol 4:31-37
4. Avner P, Simmler MC (1985) Minor histocompatibility antigens are developmentally regulated on murine embryonal carcinoma cells and their early differentiated derivatives. Cell Differ 17:115-123
5. Avner PR, Dove WF, Dubois P, Galliard JA, Guenet J-L, Jacob F, Jacob H, Shedlovsky A (1978) The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3. Immunogenetics 7:103-115
6. Bailey D (1975) Genetics of histocompatibility in mice. I. New loci and congenic lines. Immunogenetics 2:249-256
7. Becker-Follmann J, Gaa A, Bausch E, Natt E, Scherer G, von Deimling O (1997) High-resolution mapping of a linkage group on mouse chromosome 8 conserved on human chromosome 16Q. Mamm Genome 8:172-177
8. Bernstine E, Hooper M, Grandchamp S, Ephrussi B (1973) Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci USA 70:3899-3903
9. Bevan M (1975) The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med 142:1349-1364
10. Croce CM, Linnenbach A, Huebner K, Parnes JR, Margulies DH, Appella E, Seidman JG (1981) Control of expression of histocompatibility antigens (H-2) and beta 2- microglobulin in F9 teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:5754-5758
11. Demant P, Oudshoorn-Snoek M (1985) H-2 class I antigen expression on mouse teratocarcinoma cell lines. Immunogenetics 22:543-552
12. Doolittle D, Davisson M, Roderick T, Hillyard A (1990) Locus map of mouse with comparative map points of human on mouse. Mouse Genome 87:14-27
13. Finch B, Ephrussi B (1967) Retention of multiple developmental potentialities by cells of a mouse testicular teratocarcinoma during prolonged culture in vitro and their extinction upon hybridization with cells of permanent lines. Proc Natl Acad Sci USA 57:615-621
14. Forejt J, Gregorova S, Dohnal K, Nosek J (1984) Gene expression of differentiated parent in teratocarcinoma cell hybrids. Repression or reprogramming? Cell Differ 15:229-234
15. Gregorova S, Loudova M, Forejt J (1984) A gene controlling teratocarcinoma graft rejection mapped inside the t0 haplotype. Cell Differ 15:235-239
16. Johnson LL, Clipson LJ, Dove WF, Feilbach J, Maher LJ, Shedlovsky A (1983) Teratocarcinoma transplantation antigens are encoded in the H-2 region. Immunogenetics 18:137-145
17. Kahan B, Ephrussi B (1970) Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma. J Natl Cancer Inst 44:1015-1036
18. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
19. Levine AJ, Teresky AK (1981) Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles. Immunogenetics 13:405-412
20. Lisitsyn N, Segre J, Kusumi K, Lisitsyn N, Nadeau J, Frankel W, Wigler M, Lander E (1994) Direct isolation of polymorphic markers linked to a trait by genetically directed representational difference analysis. Nat Genet 6:57-63
21. Maher III LJ, Dove WF (1984) Overt expression of H-2 serotypes on EC cells is not necessary for host rejection. Immunogenetics 19:343-347
22. Morello D, Daniel F, Baldacci P, Cayre Y, Gachelin G, Kourilsky P (1982) Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells. Nature 298:260-262
23. Morello D, Gachelin G, Dubois P, Tanigaki N, Pressman D, Jacob F (1978) Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells. Transplantation 26:119-125
24. Moser AR, Johnson LL, Dove WF (1985) Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells. Immunogenetics 22:533-541
25. Moser AR, Shedlovsky A, Johnson LL (1986) H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. Immunogenetics 23:271-273
26. Mosinger B, Forejt J (1989) Transfected H-2 Kb gene as a cause of embryonal carcinoma cell rejection in vivo. Immunogenetics 29:269-272
27. Mouse Genome Database (MGD), Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, ME. World Wide Web (URL: http://www.informatics.jax.org/)
28. Ostrand-Rosenberg S, Cohan VL (1981) H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice. J Immunol 126:2190-2193
29. Ostrand-Rosenberg S, McCarthy C (1984) Resistance to murine 402AX teratocarcinoma: regulation by H-2IA and H-3 to H-13 region gens. Immunogenetics 19:77-82
30. Ostrand-Rosenberg S, Schwartzman ML, Hecht TT, Marr L (1986) Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor. Cell Immunol 99:453-460
31. Peters J (1982) Nonspecific esterases of Mus musculus. Biochem Genet 20:585-606
32. Shedlovsky A, Clipson LJ, VandeBerg JL, Dove WF (1981) Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2. Immunogenetics 13:413-419
33. Siegler EL, Tick N, Teresky AK, Rosentraus M, Levine AJ (1979) Teratocarcinoma transplantation rejection loci: an H-2-linked tumor rejection locus. Immunogenetics 9:207-220
34. Simmler MC, Avner P, Levy JP (1982) Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses. Immunogenetics 16:349-354
35. Simmler MC, Avner PR (1982) The significance of natural killer activity in the resistance of allogeneic hosts to the embryonal carcinoma cell line F9. Am J Reprod Immunol 2:301-308
36. Simmler MC, Avner PR (1985) Differential Hm antigen expression on EC cells and early differentiated derivatives. EMBO J 4:1177-1185
37. Simpson E, Linder C, Sargent E, Davisson M, Mobraaten L, Sharp J (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19-27
38. Sionov RV, Gallily R (1990) Engulfment and intracellular killing of F9 teratocarcinoma cells by non-activated murine macrophages. Int Immunol 2:291-301
39. Snell G (1981) Studies in histocompatibility. Science 213
40. Snell G, Graff R, Cherry M (1971) Histocompatibility genes of mice. XI. Evidence establishing a new histocompatibility locus, H-12, and new H-2 allele, H-2bc. Transplantation 11:525-30
41. Stern P, Gidlund M, Orn A, Wigzell H (1980) Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC. Nature 285:341-342
42. Stevens L (1970) The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol 21:364-382
43. Swartzendruber D, Cox K, Wilder M (1980) Flow cytoenzymology of the early differentiation of mouse embryonal carcinoma cells. Differentiation 16:23-30
44. Taylor B, Navin A, Phillips S (1994) PCR-amplification of simple sequence repeat variants from pooled DNA samples for rapidly mapping new mutations of the mouse. Genomics 21:626-632